Repair research
BPC-157 vs TB-500
Two repair peptides with distinct literature emphases.
Overview
This comparison separates BPC-157 and TB-500 for laboratory reference—not product selection.
BPC-157: Synthetic peptide derived from gastric juice protein, renowned for tissue repair, inflammation reduction, and GI protection capabilities. BPC-157 promotes blood vessel formation, c…
TB-500: A synthetic 7-amino acid fragment corresponding to the actin-binding region of thymosin beta-4, originally developed for equine use with retained tissue repair properties. TB-500 a…
Differences
- BPC-157 literature emphasises GI cytoprotection, angiogenesis, and localized repair models.
- TB-500 literature emphasises actin-related cell migration and thymosin β4 fragment biology.
Mechanism
BPC-157: Synthetic peptide derived from gastric juice protein, renowned for tissue repair, inflammation reduction, and GI protection capabilities. BPC-157 promotes blood…
TB-500: A synthetic 7-amino acid fragment corresponding to the actin-binding region of thymosin beta-4, originally developed for equine use with retained tissue repair…
Pharmacology
BPC-157: Pharmacokinetic detail should be read from primary literature.
TB-500: Pharmacokinetic detail should be read from primary literature.
Research
BPC-157: Tissue repair & recovery: Synthetic peptide derived from gastric juice protein, renowned for tissue repair, inflammation reduction, and GI protection capabilities. BPC-15…
TB-500: Tissue repair & recovery: A synthetic 7-amino acid fragment corresponding to the actin-binding region of thymosin beta-4, originally developed for equine use with retaine…
Summary
Distinction
- AXIOM does not provide dosing, administration, or protocol guidance.
- Catalogue links appear only where AXIOM lists a research-use product.
- Reference-only compounds remain comparison terms without implying availability.
References
- pubmed.ncbi.nlm.nih.gov/39325560/
- pubmed.ncbi.nlm.nih.gov/32334036/
- pubmed.ncbi.nlm.nih.gov/40131143/
- pubmed.ncbi.nlm.nih.gov/27847966/
- pubmed.ncbi.nlm.nih.gov/14554208/
- pubmed.ncbi.nlm.nih.gov/32445447/
- pubmed.ncbi.nlm.nih.gov/31266512/
- pubmed.ncbi.nlm.nih.gov/16609979/
Questions
Does this page recommend BPC-157 or TB-500?
No. It is an editorial comparison for research context only.
Does AXIOM provide protocol guidance?
No. Protocol and dosing decisions belong with qualified laboratory teams and source literature.
Available from AXIOM
Catalogue
Labelled strengths and batch records where available.